Pos0733 Validation Of The Sle-Das Responder Index As An Accurate And Feasible Endpoint For Sle Clinical Trials: A Post-Hoc Study In The Phase 2 And 3 Anifrolumab Clinical Trials

AuthID
 P-01A-QEW
5
Author(s)
Jesus, D
·
Matos, A
·
Doria, A
·
Inês, L
Tipo de Documento
Article
Year published
2024
Publicado
in Annals of the Rheumatic Diseases, ISSN: 0003-4967
Volume: 83, Páginas: 1004-1005
Indexing
Crossref®
Google Scholar®
Publication Identifiers
Source Identifiers
ISSN: 0003-4967
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service